IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
56.24
-0.90 (-1.58%)
Feb 21, 2025, 4:00 PM EST - Market closed
IRADIMED CORPORATION Market Cap
IRADIMED CORPORATION has a market cap or net worth of $712.75 million as of February 21, 2025. Its market cap has increased by 25.64% in one year.
Market Cap
712.75M
Enterprise Value
660.52M
1-Year Change
25.64%
Ranking
Category
Stock Price
$56.24
Market Cap Chart
Since July 16, 2014, IRADIMED CORPORATION's market cap has increased from $100.50M to $712.75M, an increase of 609.21%. That is a compound annual growth rate of 20.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 724.20M | 3.90% |
| Dec 31, 2024 | 697.00M | 16.48% |
| Dec 29, 2023 | 598.40M | 68.33% |
| Dec 30, 2022 | 355.50M | -37.66% |
| Dec 31, 2021 | 570.30M | 103.90% |
| Dec 31, 2020 | 279.70M | 4.17% |
| Dec 31, 2019 | 268.50M | 0.37% |
| Dec 31, 2018 | 267.50M | 67.29% |
| Dec 29, 2017 | 159.90M | 34.48% |
| Dec 30, 2016 | 118.90M | -61.68% |
| Dec 31, 2015 | 310.30M | 122.44% |
| Dec 31, 2014 | 139.50M | 38.81% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.92B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |